RxDoctor Payments Data

Arthur Cabrera

Anesthesiology · Louisville, CONPI 1851344105

Payments from drug & device makers

What this record shows

4 manufacturers reported payments, led by Covidien LP at 46.3% of the total. Reporting peaked in 2019 at $117 and has fallen 83.1% since, to $20 in 2024.

$162in general payments, 2019–2025

Across 7 payments — averaging $23.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Covidien LP$75
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$42
  • Merck$25
  • BD$20
$1,527,664in research payments, 2019–2025

Across 92 payments — averaging $16,605 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$460K
  • Covidien LP$375K
  • Fresenius USA Inc.$271K
  • Welch Allyn$248K
  • GE HealthCare$68K
  • Baxter Healthcare$65K
  • plus $41K from 1 others

What the payments were for

  • Speaking & faculty fees$7546%
  • Food & beverage$8754%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$162 in reported general payments places this provider in the 70th percentile of 921 anesthesiology providers in Colorado.

See all anesthesiology providers in Colorado

Other anesthesiology in Louisville

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →